Description

Altri importanti lavori presentati all’ASCO 2024 sono stati contemporaneamente pubblicati sul Journal of Clinical Oncology. In rete possiamo trovare anche tutti gli abstracts di ASCO 2024 e il “prezioso” ASCO Educational Book.  

Riferimenti bibliografici

• Abstracts ASCO 2024
• ASCO Educational Book
• Solomon BJ, et al. Lorlatinib Versus Crizotinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study. J Clin Oncol 2024: JCO2400581. doi: 10.1200/JCO.24.00581. Epub ahead of print.
• Paz-Ares LG, et al. Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study. J Clin Oncol 2024: JCO2400733. doi: 10.1200/JCO.24.00733. Epub ahead of print.